Changes in male permanent contraception as partner access to long-acting reversible contraception (LARC) increases: an analysis of the National Survey for Family Growth, 2006-2010 versus 2017-2019.

Contraceptive Agents, Female Contraceptive Agents, Male intrauterine devices long-acting reversible contraception

Journal

BMJ sexual & reproductive health
ISSN: 2515-2009
Titre abrégé: BMJ Sex Reprod Health
Pays: England
ID NLM: 101715577

Informations de publication

Date de publication:
16 Jul 2024
Historique:
received: 26 04 2024
accepted: 06 07 2024
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 16 7 2024
Statut: aheadofprint

Résumé

Male permanent contraception (PC), that is, vasectomy, is an effective way of preventing pregnancy. In the United States, male PC use has historically been concentrated among higher-educated/higher-income males of White race. In the last decade, use of long-acting reversible contraception (LARC) has increased dramatically. We sought to understand how sociodemographic patterns of male PC have changed in the context of rising LARC use. We examined the nationally representative male public use files of the National Survey for Family Growth (NSFG) across five survey waves. Our outcome was primary contraceptive use at last sexual encounter within 12 months. Using four-way multinomial logistic regressions (male PC, female PC, LARC, lower-efficacy methods), we compared sociodemographic factors predictive of male PC use versus reported partner LARC use between 2006-2010 (early) and 2017-2019 (recent) waves. We included 15 964 participants. From 2006 to 2019, there were absolute declines in male PC from 8.0% to 6.8%, while male-reported partner LARC use increased three-fold, from 3.4% to 11.0%. Among the highest economic strata, use of LARC converged with male PC. In adjusted analyses, high income significantly associated with male PC use in the early wave (OR 4.6 (1.4, 14.8)), but no longer in the recent wave (OR 0.9 (0.2, 4.2)). Marital status remained a significant but declining predictor of male PC across survey waves, and instead, by 2019, number of children newly emerged as the strongest predictor of male PC use. Sociodemographic variables associated with vasectomy use are evolving, especially among high-income earners.

Identifiants

pubmed: 39013638
pii: bmjsrh-2024-202372
doi: 10.1136/bmjsrh-2024-202372
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Isabel Beshar (I)

Obstetrics & Gynecology, Stanford University, Stanford, California, USA ibeshar@stanford.edu.

Jodi Y So (JY)

School of Medicine, Stanford University, Stanford, California, USA.

Kate A Shaw (KA)

Obstetrics & Gynecology, Stanford University, Stanford, California, USA.

Erica P Cahill (EP)

Obstetrics & Gynecology, Stanford University, Stanford, California, USA.

Jonathan Glazer Shaw (JG)

Division of Primary Care & Population Health, Stanford University, Stanford, California, USA.

Classifications MeSH